DEA issues first federal registrations to 900-plus medical marijuana dispensaries; DEA sets a Nov. 29 supply-chain sourcing deadline; House bill would put a 50% tariff on China-origin cannabinoid imports.

NEW REALM BREWING

Daily Compliance Brief

▶  Listen to today's brief (~2 min)

Vol. 1 • Edition 79 • Saturday, October 31, 2026 • Alcohol & Hemp/THC Regulation • Federal + All 50 States

Good morning — here's the regulatory picture for alcohol and hemp/THC beverages, readable in about three minutes. Every headline links to the original source.

Top Story

DEA issues first federal registrations to more than 900 medical marijuana dispensaries

FEDERAL • Marijuana Moment • Oct 30

Attorney General Todd Blanche announced Friday that DEA granted federal registrations to more than 900 state-licensed medical marijuana dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia — what the Justice Department called the first phase of implementing the move of state-licensed medical marijuana to Schedule III. A DEA list published the same day shows nearly 7,000 businesses have applied; DOJ said registrants must meet federal security, recordkeeping and inventory-control requirements, and the Associated Press reported registration could open ordinary federal tax deductions long unavailable to the industry. DEA said manufacturer and distributor applications are entering review next.

Why it matters: the registration rolls now define which cannabis-sector businesses hold federal protections — a due-diligence reference point for any distributor or retailer evaluating partners in the seven covered states, with more states and license types queued behind them.

Federal

DEA sets Nov. 29 deadline for registered businesses to build compliant supply chains

FEDERAL • Marijuana Moment • Oct 30

In a four-page guidance document issued alongside the registrations, DEA said registrants and timely applicants must source cannabis only from other DEA registrants or timely applicants by November 29, verify each partner's document control number on the Diversion Control website, and keep records of the due diligence performed. Trading with non-qualifying entities "could be potential grounds for denial" of an application or revocation of a registration, the agency said; inventory acquired before the guidance may still be sold.

Why it matters: a hard 30-day compliance date — every supplier and customer in the registered channel now needs verified federal status and a paper trail.

House bill would add a 50% tariff and import testing to China-origin cannabinoid products

U.S. HOUSE • Marijuana Moment • Oct 30

Rep. Val Hoyle (D-OR) filed the Protecting American Hemp Farmers Act (H.R. 10929), which would impose an additional duty of 50% of the customs value on cannabinoid articles originating from China, direct Customs and Border Protection to work with FDA on testing imported cannabinoid products for heavy metals, pesticides, solvents and synthetic byproducts, create new tariff-schedule categories for cannabinoid isolates and distillates, and require annual public import reports. The bill has just been introduced and has seen no further action.

Why it matters: if enacted, imported cannabinoid inputs used in hemp beverages would carry materially higher landed costs, shifting sourcing math toward domestic suppliers.

Report: alcohol-company lobbyists urged state attorneys general to back the federal hemp ban

FEDERAL • Marijuana Moment • Oct 30

Politico reported, citing emails obtained through public-records requests, that lobbyists working for Anheuser-Busch, Molson Coors and Diageo encouraged state attorneys general to sign an August letter — ultimately joined by a bipartisan group of 35 AGs — urging Congress to reject any effort to delay or weaken the scheduled hemp THC ban. Other industry voices have taken the opposite position: the National Restaurant Association asked congressional leaders to delay the ban and replace it with a regulatory framework, and Rep. Morgan Griffith (R-VA) has said a post-election reconciliation bill could carry hemp THC regulation before the December 11 effective date.

Why it matters: the positions staked out in the lame-duck session will decide whether hemp THC beverages remain sellable after Dec. 11 — a six-week planning horizon for anyone carrying the category.

Around the States

Minnesota: DEA declines registrations under the state's dual-license structure

MINNESOTA • Marijuana Moment • Oct 30

DEA sent an order to show cause to a Minneapolis dispensary, saying Minnesota's combined medical and adult-use license "falls outside" the federal definition of a state medical license and citing, among other factors, that state law lets dispensaries sell hemp-derived cannabinoid products. The business has 30 days to request a hearing or submit a corrective action plan. Minnesota's Office of Cannabis Management said the order does not affect state law authorizing its programs and that medical cannabis remains available to patients. Licensing impact: holders of dual-purpose licenses — the structure used statewide in Minnesota — are for now outside the federal registration channel, while the 900-plus registrations granted Friday went to states with medical-only licensing.

Why it matters: in dual-license states, retailers and distributors cannot assume their in-state partners hold or will receive federal registration — status must be checked license by license.

On the Radar

Nov. 3 — Massachusetts votes on Question 8, which would repeal the laws allowing retail sale, regulation and taxation of adult-use marijuana (the medical program would continue); if passed, it takes effect January 1, 2028.

Nov. 12 — Synthetic cannabinoids not naturally produced by the cannabis plant are excluded from the federal hemp definition — this date was not moved by the September delay. Illinois' hemp overhaul also takes effect the same day, ending THC-drink sales through liquor retailers there.

Dec. 11 — The federal 0.4 mg total-THC-per-container limit takes effect for most hemp products unless Congress acts first; several competing bills are pending and Rep. Griffith has pointed to the lame-duck session as the window.

 

Jeremy Barnes | Chief Financial Officer, New Realm Brewing Co.

Prepared for New Realm's leadership team and valued partners. This brief is for general informational purposes only and is not legal advice; it is compiled with AI assistance from the linked sources — please confirm details at the link before acting on them.

Subscribe   Unsubscribe

Buttons not working? Reply to this email with the word subscribe or unsubscribe.

Read online & browse the archive: compliance.newrealmbrewing.com • Listen & follow: Apple Podcasts • Spotify • Amazon Music • All apps

» jbarnes@newrealmbrewing.com

» newrealmbrewing.com

» Facebook | Instagram | Twitter | LinkedIn

Audio transcript (~2 min read)

This is the New Realm Compliance Brief, Volume One, Edition Seventy-Nine, for Saturday, October Thirty-First.

Our top story. Attorney General Todd Blanche announced Friday that the Drug Enforcement Administration has granted federal registrations to more than nine hundred state-licensed medical marijuana dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. The Justice Department called it the first phase of implementing the move of state-licensed medical marijuana to Schedule Three. A list published the same day shows nearly seven thousand businesses have applied. The Associated Press reported that registration could open ordinary federal tax deductions long unavailable to the industry.

Also from the D E A: a new guidance document gives registrants and timely applicants until November twenty-ninth to source cannabis only from other registered or timely-applicant companies, with verified document control numbers and due-diligence records. The agency said trading with non-qualifying entities could be grounds for denial or revocation.

In Minnesota, the D E A sent an order to show cause to a Minneapolis dispensary, saying the state's combined medical and adult-use license falls outside the federal definition of a state medical license. Minnesota's Office of Cannabis Management said the order does not change state law and medical cannabis remains available.

In Congress, Representative Val Hoyle of Oregon filed a bill that would put an additional fifty percent tariff on China-origin cannabinoid imports and require federal testing of imported cannabinoid products. And Politico reported that lobbyists for three major alcohol companies urged state attorneys general to back the scheduled federal hemp ban, while other industry groups asked Congress to regulate hemp drinks instead.

On the radar: Massachusetts votes Tuesday on Question Eight, which would repeal adult-use retail marijuana. The federal synthetic cannabinoid exclusion takes effect November twelfth, and the broader hemp T H C limit on December eleventh.

Full details and source links are in today's email. This update is for general information only — it is not legal advice.